Cel Sci Corp. (NYSE American: CVM)
CEL-SCI Corporation is a late clinical-stage biotechnology company focused on Multikine (Leukocyte Interleukin, Injection), a true first-line cancer therapy, which is designed to help the immune system target the tumor.
For more information including SEC filings please visit: https://cel-sci.com/ .